Cargando…
WX-132-18B, a novel microtubule inhibitor, exhibits promising anti-tumor effects
Cancer drug researchers have been seeking microtubule-inhibiting agents (MIAs) with higher bioactivity and lower toxicity than currently marketed drugs. WX-132-18B, a novel structural compound synthesized at our institute, specifically bound to the colchicine-binding site on tubulin rather than the...
Autores principales: | Guan, Fang, Ding, Rui, Zhang, Qi, Chen, Wei, Li, Feifei, Long, Long, Li, Wei, Li, Linna, Yang, Dexuan, Xie, Lan, Yuan, Shoujun, Wang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641089/ https://www.ncbi.nlm.nih.gov/pubmed/29069746 http://dx.doi.org/10.18632/oncotarget.17710 |
Ejemplares similares
-
wxPython in action
por: Rappin, Noel, 1971-
Publicado: (2006) -
wxPython in Action
por: Rappin, Noel, et al.
Publicado: (2006) -
Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037
por: Haagensen, Emma J., et al.
Publicado: (2016) -
Fine‐tuning the amylose content of rice by precise base editing of the Wx gene
por: Xu, Yang, et al.
Publicado: (2020) -
Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing
por: ZHANG, QI, et al.
Publicado: (2016)